Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Lymphoma 45Lymphoma, Large B-Cell, Diffuse 31Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Burkitt Lymphoma 22Neuroblastoma 20Leukemia 20Lymphoma, Non-Hodgkin 19Sarcoma 12Multiple Myeloma 12Lymphoma, Follicular 12Central Nervous System Neoplasms 12HIV Infections 11Hodgkin Disease 10Lymphoma, Large-Cell, Immunoblastic 9Acquired Immunodeficiency Syndrome 9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, Mantle-Cell 8Leukemia, Lymphocytic, Chronic, B-Cell 7Neuroectodermal Tumors, Primitive, Peripheral 6Neoplasms, Plasma Cell 6Lymphoma, Large-Cell, Anaplastic 5Lymphoma, B-Cell, Marginal Zone 5Lymphoma, B-Cell 5Leukemia, Biphenotypic, Acute 5Sarcoma, Kaposi 4Sarcoma, Ewing 4Rhabdomyosarcoma 4Neoplasms 4Lymphoma, T-Cell 4Dendritic Cell Sarcoma, Interdigitating 4

Interventions

Trastuzumab 2Paclitaxel 2Leucovorin 2Fluorouracil 2Carboplatin 2veliparib 1tipifarnib 1entinostat 1Vincristine 1Taxes 1Semaxinib 1Oxaliplatin 1Interleukin-12 Subunit p35 1Interleukin-12 1Floxuridine 1Etoposide 1Epirubicin 1Doxorubicin 1Cyclophosphamide 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Neoplasms, Unknown Primary × Vincristine × Clear all
NCT00022178 2013-09-20

Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin

National Cancer Institute (NCI)

Phase 3 Unknown
Tumor-Agnostic

Neoplasms, Unknown Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡